TMB-H
Showing 1 - 25 of 2,356
Pan Tumor Trial in Worldwide (Nivolumab, Ipilimumab)
Active, not recruiting
- Pan Tumor
- Nivolumab
- Ipilimumab
-
Santa Monica, California
- +59 more
Jul 26, 2022
Colorectal Cancer Trial in Guangzhou (PD-1 antibody + cox inhibitor)
Unknown status
- Colorectal Cancer
- PD-1 antibody + cox inhibitor
-
Guangzhou, Guangdong, China
- +1 more
Jun 25, 2020
Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)
Recruiting
- Melanoma
- +4 more
- Pembrolizumab
-
Aurora, Colorado
- +18 more
Jan 5, 2023
Advanced NSCLC Trial in Worldwide (Pembrolizumab, Favezelimab, Lenvatinib)
Active, not recruiting
- Advanced Non-Small Cell Lung Cancer
- Pembrolizumab
- +3 more
-
Tempe, Arizona
- +80 more
Aug 23, 2022
Constitutional Mismatch Repair Deficiency Syndrome, Hematopoietic and Lymphoid Cell Tumor, Lynch Syndrome Trial in Canada,
Withdrawn
- Constitutional Mismatch Repair Deficiency Syndrome
- +11 more
- Biospecimen Collection
- +2 more
-
Palo Alto, California
- +8 more
Sep 9, 2022
Advanced Solid Tumors Trial in United States (zimberelimab)
Active, not recruiting
- Advanced Solid Tumors
-
Riverside, California
- +10 more
Dec 6, 2022
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
NSCLC Trial in Worldwide (Pembrolizumab, Pemetrexed, Carboplatin)
Solid Tumor, Adult, Advanced Solid Tumor, Metastatic Solid Tumor Trial in United Kingdom, United States (Etigilimab dosing,
Recruiting
- Solid Tumor, Adult
- +2 more
- Etigilimab dosing
- Nivolumab
-
Phoenix, Arizona
- +15 more
Jun 6, 2022
Precision-Based Genomics in Prostate Cancer
Recruiting
- Prostate Cancer
-
La Jolla, California
- +4 more
Jul 28, 2022
Locally Advanced Rectal Carcinoma, Circulating Tumor DNA Trial in Beijing (circulating tumor DNA)
Recruiting
- Locally Advanced Rectal Carcinoma
- Circulating Tumor DNA
- circulating tumor DNA
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Oct 27, 2022
Adenocarcinoma of the Colon Trial in London (Pembrolizumab)
Recruiting
- Adenocarcinoma of the Colon
-
London, United KingdomUniversity College Hospital
Jul 20, 2022
Colorectal Cancer Trial
Completed
- Colorectal Cancer
- (no location specified)
Nov 8, 2023
HIV, Medication Adherence Trial in Bangalore (Tel-me-box with reminder features, Tel-me-box)
Active, not recruiting
- HIV
- Medication Adherence
- Tel-me-box with reminder features
- Tel-me-box
-
Bangalore, Karnataka, IndiaSt. John & Research Institute/St John & Medical College & Hospit
Feb 22, 2022
Lung Tumor Malignant Trial in Jeollanam-do (Atezolizumab Injection [Tecentriq])
Unknown status
- Lung Neoplasm Malignant
- Atezolizumab Injection [Tecentriq]
-
Jeollanam-do, 전라남도, Korea, Republic ofChonnam National University Hwasun Hospital
Jan 26, 2021
Advanced Solid Tumors Trial in Australia, Korea, Republic of, Thailand (YBL-006)
Active, not recruiting
- Advanced Solid Tumors
-
Macquarie, New South Wales, Australia
- +6 more
Dec 1, 2022
Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)
Recruiting
- Advanced Unresectable or Metastatic Solid Malignancy
- Entrectinib
- +11 more
-
Birmingham, Alabama
- +50 more
Aug 10, 2022
Generation ofArtificial Intelligence Algorithm Based on Analysis
Not yet recruiting
- Metastatic Melanoma
- Photo
- (no location specified)
May 3, 2023
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Recruiting
- Non Small Cell Lung Cancer
- +3 more
- Core needle biopsy
-
Madison, WisconsinElephas
Aug 4, 2022
Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)
Not yet recruiting
- Ovarian Neoplasms
- +5 more
- Dostarlimab
- +4 more
- (no location specified)
Sep 3, 2023